Molecular basis for action of bioactive glasses as bone graft substitute

Scandinavian Journal of Surgery

Volumn 95, Issue 2, 2006, Pages 95-102

  Valimaki V V ^a   Aro, Hannu T ^a  

^a UNIVERSITY OF TURKU   (Finland)

Author keywords

Bioactive glass; Bioceramics; Bone grafts

Indexed keywords

BIOMATERIAL; BONE MORPHOGENETIC PROTEIN 2; CALCIUM PHOSPHATE CERAMIC; GLASS; HYDROXYAPATITE; MICROSPHERE; PHOSPHONIC ACID DERIVATIVE; SILICON DIOXIDE; ZOLEDRONIC ACID;

ABSORPTION; ALLOGRAFT; BONE GRAFT; BONE GROWTH; BONE MARROW CELL; BONE TURNOVER; CHEMICAL COMPOSITION; FRACTURE HEALING; FRAGILITY FRACTURE; GENE THERAPY; GENE TRANSFER; HUMAN; IN VIVO STUDY; NONHUMAN; OSSIFICATION; OSTEOLYSIS; REVIEW;

EID: 33745079582     PISSN: 14574969     EISSN: None     Source Type: Journal    
DOI: 10.1177/145749690609500204     Document Type: Review

References (36)

1. van der Donk S, Weernink T, Buma P, Aspenberg P, Slooff TJ, Schreurs BW: Rinsing morsellized allografts improves bone and tissue ingrowth. Clin Orthop 2003;408:302-310
2. Galea G, Kopman D, Graham BJM: Supply and demand of bone allograft for revision hip surgery in Scotland. J Bone Joint Surg 1998;80B:595-599
3. Aro HT, Aho AJ: Clinical use of bone allografts. Ann Med 1993;25:403-412
4. Hench LL, Splinter RJ, Allen WC, Greenlee TK: Bonding mechanisms at the interface of ceramic prosthetic materials. J Biomed Mater Res Symp 1971;2:117-141
5. Hench LL, West JK: Biological applications of bioactive glasses. Life Chemistry Reports 1996;13:187-241
6. Brink M, Turunen T, Happonen RP, Yli-Urpo A: Compositional dependence of bioactivity of glasses in the system Na2O-K2O-MgO-CaO-B2O3-P2O5-SiO2. J Biomed Mater Res 1997;37:114-121
7. Välimäki V-V, Yrjans JJ, Vuorio E, Aro HT: Combined effect of bone morphogenetic protein-2 gene therapy and bioactive glass microspheres in enhancement of new bone formation. J Biomed Mater Res 2005;75:501-509
8. Välimäki V-V, Yrjans JJ, Vuorio E, Aro HT: Molecular biological evaluation of adjunct treatment with BMP-2 gene transfer and bioactive glass microspheres in enhancement of new bone formation. Tissue Engineering 2005;11:387-394
9. Rafiee B, Inoue N, Jones K, Deitz L, Aro HT, Chao EY: Trabecular microstructure in the early stage of cortical defect repair. Orthopaedic Research Society, 46th Annual meeting transactions 2000;25
10. Xynos ID, Hukkanen MV, Batten JJ, Buttery LD, Hench LL, Polak JM: Bioglass 45S5 stimulates osteoblast turnover and enhances bone formation in vitro: implications and applications for bone tissue engineering. Calcif Tissue Int 2000;67:321-329
11. Loty C, Sautier JM, Tan MT, Oboeuf M, Jallot E, Boulekbache H, Greenspan D, Forest N: Bioactive glass stimulates in vitro osteoblast differentiation and creates a favorable template for bone tissue formation. J Bone Miner Res 2001;16:231-239
12. Bosetti M, Cannas M: The effect of bioactive glasses on bone marrow stromal cells differentiation. Biomaterials 2005;26:3873-3879
13. Radin S, Reilly G, Bhargave G, Leboy PS, Ducheyne P: Osteogenic effects of bioactive glass on bone marrow stromal cells. J Biomed Mater Res 2005;73:21-29
14. Hench LL, Wilson J: Surface-active biomaterials. Science 1984;226:630-636
15. Ducheyne P, Qiu Q: Bioactive ceramics: the effect of surface reactivity on bone formation and bone cell function. Biomaterials 1999;20:2287-2303
16. El-Ghannam A, Ducheyne P, Shapiro IM: Effect of serum proteins on osteoblast adhesion to surface-modified bioactive glass and hydroxyapatite. J Orthop Res 1999;17:340-345
17. Schepers EJ, Ducheyne P: Bioactive glass particles of narrow size range for the treatment of oral bone defects: a 1-24 month experiment with several materials and particle sizes and size ranges. J Oral Rehabil 1997;24:171-181
18. Oonishi H, Hench LL, Wilson J, Sugihara F, Tsuji E, Kushitani S, Iwaki H: Comparative bone growth behavior in granules of bioceramic materials of various sizes. J Biomed Mater Res 1999;44:31-43
19. Itälä AI, Ylänen HO, Ekholm C, Karlsson KH, Aro HT: Pore diameter of more than 100 microm is not requisite for bone ingrowth in rabbits. J Biomed Mater Res 2001;58:679-683
20. Xynos ID, Edgar AJ, Buttery LD, Hench LL, Polak JM: Gene-expression profiling of human osteoblasts following treatment with the ionic products of Bioglass 45S5 dissolution. J Biomed Mater Res 2001;55:151-157
21. Xynos ID, Edgar AJ, Buttery LD, Hench LL, Polak JM: Ionic products of bioactive glass dissolution increase proliferation of human osteoblasts and induce insulin-like growth factor II mRNA expression and protein synthesis. Biochem Biophys Res Commun 2000b;276:461-465
22. Gao T, Aro HT, Ylänen H, Vuorio E: Silica-based bioactive glasses modulate expression of bone morphogenetic protein-2 mRNA in Saos-2 osteoblasts in vitro. Biomaterials 2001;22:1475-1483
23. Govender S, Csimma C, Genant HK, Valentin-Opran A, Amit Y, Arbel R, Aro H, Atar D, Bishay M, Borner MG, Chiron P, Choong P, Cinats J, Courtenay B, Feibel R, Geulette B, Gravel C, Haas N, Raschke M, Hammacher E, van der Velde D, Hardy P, Holt M, Josten C, Ketterl RL, Lindeque B, Lob G, Mathevon H, McCoy G, Marsh D, Miller R, Munting E, Oevre S, Nordsletten L, Patel A, Pohl A, Rennie W, Reynders P, Rommens PM, Rondia J, Rossouw WC, Daneel PJ, Ruff S, Ruter A, Santavirta S, Schildhauer TA, Gekle C, Schnettler R, Segal D, Seiler H, Snowdowne RB, Stapert J, Taglang G, Verdonk R, Vogels L, Weckbach A, Wentzensen A, Wisniewski T; BMP-2 Evaluation in Surgery for Tibial Trauma (BESTT) Study Group: Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patients. J Bone Joint Surg Am 2002;84:2123-2134
24. Baltzer AW, Lattermann C, Whalen JD, Wooley P, Weiss K, Grimm M, Ghivizzani SC, Robbins PD, Evans CH: Genetic enhancement of fracture repair: healing of an experimental segmental defect by adenoviral transfer of the BMP-2 gene. Gene Ther 2000;7:734-739
25. Välimäki VV, Moritz N, Yrjans JJ, Vuorio E, Aro HT: Effect of zoledronic acid on incorporation of a bioceramic bone graft substitute. Bone 2006;38:432-443
26. Keating JF, McQueen MM: Substitutes for autologous bone graft in orthopaedic trauma. J Bone Joint Surg Br 2001;83:3-8
27. Finkemeier CG: Bone-grafting and bone-graft substitutes. J Bone Joint Surg Am 2002;84:454-464
28. Reck R: Tissue reactions to glass ceramics in the middle ear. Clin Otolaryngol Allied Sci 1981;6:63-65
29. Aitasalo K, Kinnunen I, Palmgren J, Varpula M: Repair of orbital floor fractures with bioactive glass implants. J Oral Maxillofac Surg 2001;59:1390-1395
30. Suominen E, Kinnunen J: Bioactive glass granules and plates in the reconstruction of defects of the facial bones. Scand J Plast Reconstr Surg Hand Surg 1996;30:281-289
31. Peltola M, Suonpää J, Aitasalo K, Varpula M, Yli-Urpo A, Happonen RP: Obliteration of the frontal sinus cavity with bioactive glass. Head Neck 1998;20:315-319
32. Stanley HR, Hall MB, Colaizzi F, Clark AE: Residual alveolar ridge maintenance with a new endosseous implant material. J Prosthet Dent 1987;58:607-613
33. Turunen T, Peltola J, Yli-Urpo A, Happonen RP: Bioactive glass granules as a bone adjunctive material in maxillary sinus floor augmentation. Clin Oral Implants Res 2004;15:135-141
34. Larmas E, Sewón L, Luostarinen T, Kangasniemi I, Yli-Urpo A: Bioactive glass in periodontal defects. Initial findings of soft tissue and osseous repair. In: Wilson J, Hench LL, Greenspan D (eds.). Bioceramics, 1995, vol. 8. pp. 279-284. Oxford: Elsevier Science
35. Wilson J, Douek E, Rust K: Bioglass® middle ear devices: Ten year clinical results. In: Wilson J, Hench LL, Greenspan D (eds.). Bioceramics, 1995, vol 8. pp. 239-245. Oxford: Elsevier Science
36. Heikkilä JT, Mattila KT, Andersson ÖH, Yli-Urpo A, Aho AJ: Behaviour of bioactive glass in human bone. In: Wilson J, Hench LL, Greenspan D (eds.). Bioceramics, 1995, vol. 8. pp. 35-40. Oxford: Elsevier Science